SEP 07, 2016 10:30 AM PDT
Diagnostic Development and Laboratory Response to Infectious Disease Outbreaks
Presented at the Microbiology & Immunology Virtual Event
CONTINUING EDUCATION (CME/CE/CEU) CREDITS: P.A.C.E. CE | Florida CE
2 2 100

Speakers:
  • Assistant Professor, Pathology & Immunology, and Pediatrics, Baylor College of Medicine
    Biography
      Paula A Revell PhD D(ABMM) obtained her bachelors degrees at Washington University in St Louis, and her PhD from the Washington University School of medicine where studied the bacterial pathogenesis of Yersinia enterocolitica in Dr Virginia Miller's laboratory. Dr Revell's post-doctoral studies included work on tumor immunology in Dr Timothy Ley's laboratory followed by a fellowship in Medical and Public Health Laboratory Microbiology at Washington University, Barnes-Jewish Hospital, and St. Louis Children's Hospital, Department of Pathology & Immunology under the direction of Drs Mike Dunne and Greg Storch. Dr Revell is currently an assistant professor of Pathology and Pediatrics at Baylor College of Medicine and Clinical liaison in the medical microbiology laboratories at Texas Children's Hospital. Her former positions include assistant professor at University of Texas Southwestern School of Medicine, departments of pediatrics and pathology, Director of Medical Microbiology at Children's Medical Center of Dallas, and Director of Medical Microbiology laboratories at Texas Children's Hospital.
      Dr Revell has a strong interest in pediatric microbiology with a focus on molecular diagnostics, as well as an interest in the evolution of gram negative antimicrobial resistance.

    Abstract:

    The field of infectious disease diagnostics is ever changing with both newly identified infections such as SARS, Ebola, and Zika virus as well as yearly epidemics and potential for pandemic with pathogens that constantly circulate among us such as Influenza.  The ability of the laboratory to quickly respond to outbreak situations is critical.  This talk will provide an overview of the processes involved in developing, validating and implementing new diagnostic tests in the time sensitive setting of infectious disease outbreaks.


    Show Resources
    Loading Comments...